PURPOSE: To assess the value of P760, a gadolinium chelate with slow inters
titial diffusion and high relaxivity, fdr magnetic resonance (MR) imaging o
f acute myocardial infarction in pigs.
MATERIALS AND METHODS: First-pass gradient-echo MR imaging and spin-echo MR
imaging were performed with P760 and then with gadoterate meglumine in eig
ht pigs with occlusive acute myocardial infarction. P760 signal intensity e
nhancement and clearance were compared with those of gadoterate meglumine.
RESULTS: The first-pass enhancement ratio of P760 in normal myocardium was
higher than that in infarcted myocardium (1.37 +/- 0.06 [SEM] vs 1.05 +/- 0
.03, P = .03). The myocardial first pass showed a blood pool-like curve for
P760. The blood pool enhancement ratio 40 seconds after injection was high
er for P760 than for gadoterate meglumine (left ventricular cavity, 1.75 +/
- 0.06 vs 1.45 +/- 0.06, P = .009). Spin-echo MR imaging showed improved co
ntrast between normal and infarcted myocardium after P760 administration: T
he ratio before contrast material administration was 0.21 +/- 0.03, that at
15 minutes was 0.48 +/- 0.05 (P = .002), and that at 25 minutes was 0.47 /- 0.07 (P = .003).
CONCLUSION: P760 is an MR imaging contrast agent characterized by low diffu
sion, a blood pool effect soon after low-dose administration, and fast elim
ination. This agent is useful for improved myocardial perfusion MR imaging
of acute myocardial infarction.